: Purity determination. The purity of the five constructs was evaluated by absorbance measurement at 220 nm using RP-HPLC. Table 1 . Figure S4 : Analysis of binding affinity to HSA. Representative experimental sensorgrams (solid) with fitted curves (dashed) from SPR analysis for the five DOTA-conjugated ABDfused anti-HER3 affibody constructs. Immobilized HSA was subjected to four concentrations of each construct (1.5625, 3.125, 6.25 and 12.5 nM) . Monovalent affinities to HSA, based on a Langmuir 1:1 model, are presented in Table 1 . 
